bioAffinity Technologies, Inc. (BIAF) Stock Forecast
BIAF analyst forecast
as of October 17, 2026- Analyst consensus
- —
- Price target
- $6.00 average of analyst targets
- Upside to target
- +60.9% from the latest close
- Next earnings
- November 13, 2026
- 52-week range
- $3.56 – $71.10
BIAF price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
BIAF earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (2026) | −$8.10 | −$8.10 | −$8.10 | −$14.40 | +43.8% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
BIAF revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (2026) | $7.3M | $7.3M | $7.3M | +20.0% | 1 |
BIAF EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BIAF revenue: reported and forecast
BIAF EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (2026) | −$6.30 | −$5.40 | −$5.40 | −$5.40 | −$8.10 | +28.6% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
BIAF earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; BIAF beat in 2 of 9.
What analysts expect from BIAF
The average price target is $6.00, 60.9% above the latest close of $3.73. For 2026 the average estimate is −$8.10 per share on revenue of $7.3 million. bioAffinity Technologies beat the EPS estimate in 2 of the last 9 quarters.
Related: BIAF income statement, BIAF key metrics, BIAF chart. See the BIAF stock overview for the latest quote and news.
BIAF forecast FAQ
What is bioAffinity Technologies's price target?
The average analyst price target for bioAffinity Technologies is $6.00, 60.9% above the latest close of $3.73.
When does bioAffinity Technologies report earnings?
bioAffinity Technologies is expected to report results for the quarter ending September 30, 2026 on November 13, 2026.
Does bioAffinity Technologies usually beat earnings estimates?
bioAffinity Technologies reported EPS at or above the analyst estimate in 2 of the last 9 quarters.